Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Connect Biopharma Holdings (CNTB) Interest & Investment Income (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Interest & Investment Income for 2 consecutive years, with $384000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 54.77% to $384000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, down 49.07% year-over-year, with the annual reading at $2.3 million for FY2025, 49.07% down from the prior year.
  • Interest & Investment Income hit $384000.0 in Q4 2025 for Connect Biopharma Holdings, down from $545000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q1 2024 to a low of $384000.0 in Q4 2025.